Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 43, Issue 1, Pages 16-29
Publisher
Wiley
Online
2015-10-30
DOI
10.1111/apt.13446
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Significant Variations in Elastometry Measurements Made Within Short-term in Patients With Chronic Liver Diseases
- (2015) Fabio Nascimbeni et al. Clinical Gastroenterology and Hepatology
- FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States Practice
- (2015) Elliot B. Tapper et al. Clinical Gastroenterology and Hepatology
- An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards
- (2015) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
- (2015) JOURNAL OF HEPATOLOGY
- Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis
- (2014) D. T. Chao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- FibroTest/Fibrosure for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis
- (2014) Nermin N Salkic et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C
- (2014) Emmanuel A. Tsochatzis et al. HEPATOLOGY
- Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)
- (2014) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- The Effectiveness of Noninvasive Biomarkers to Predict Hepatitis B-Related Significant Fibrosis and Cirrhosis: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy
- (2014) Xue-Ying Xu et al. PLoS One
- Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: “APRI c’est fini ?”
- (2014) Hugo Perazzo et al. Clinics and Research in Hepatology and Gastroenterology
- Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2013) Roger Chou et al. ANNALS OF INTERNAL MEDICINE
- The State of US Health, 1990-2010
- (2013) Christopher J. L. Murray JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard
- (2013) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)
- (2013) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C
- (2012) Laurent Castera GASTROENTEROLOGY
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
- (2012) Khayriyyah Mohd Hanafiah et al. HEPATOLOGY
- Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
- (2012) Thierry Poynard et al. PLoS One
- Use of 3x2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests: meta-analytical evaluation of coronary CT angiography studies
- (2012) G. M. Schuetz et al. BMJ-British Medical Journal
- Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
- (2011) Thierry Poynard et al. BMC GASTROENTEROLOGY
- FibroStic: A large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted
- (2011) Mona Munteanu et al. JOURNAL OF HEPATOLOGY
- Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard
- (2011) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease
- (2011) Michael H. Miller et al. LIVER INTERNATIONAL
- FibroTest® and Fibroscan® performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate
- (2011) Thierry Poynard et al. Clinics and Research in Hepatology and Gastroenterology
- Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
- (2010) Thierry Poynard et al. BMC GASTROENTEROLOGY
- Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses
- (2010) Gloria Woo et al. GASTROENTEROLOGY
- First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy
- (2010) Thierry Poynard JOURNAL OF HEPATOLOGY
- How to Measure the Diagnostic Accuracy of Noninvasive Liver Fibrosis Indices: The Area Under the ROC Curve Revisited
- (2008) J. Lambert et al. CLINICAL CHEMISTRY
- Exceeding the limits of liver histology markers
- (2008) Shruti H. Mehta et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now